首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism
【2h】

Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism

机译:抑癌基因座13q14.3处的等位基因沉默表明表观遗传的抑癌机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genomic material from chromosome band 13q14.3 distal to the retinoblastoma locus is recurrently lost in a variety of human neoplasms, indicating an as-yet-unidentified tumor-suppressor mechanism. No pathogenic mutations have been found in the minimally deleted region until now. However, in B cell chronic lymphocytic leukemia tumors with loss of one copy of the critical region, respective candidate tumor-suppressor genes are down-regulated by a factor >2, which would be expected by a normal gene-dosage effect. This finding points to an epigenetic pathomechanism. We find that the two copies of the critical region replicate asynchronously, suggesting differential chromatin packaging of the two copies of 13q14.3. Although we also detect monoallelic silencing of genes localized in the critical region, monoallelic expression originates from either the maternal or paternal copy, excluding an imprinting mechanism. DNA methylation analyses revealed one CpG island of the region to be methylated. DNA demethylation of this CpG island and global histone hyperacetylation induced biallelic expression, whereas replication timing was not affected. We propose that differential replication timing represents an early epigenetic mark that distinguishes the two copies of 13q14.3, resulting in differential chromatin packaging and monoallelic expression. Accordingly, deletion of the single active copy of 13q14.3 results in significant down-regulation of the candidate genes and loss of function, providing a model for the interaction of genetic lesions and epigenetic silencing at 13q14.3 in B cell chronic lymphocytic leukemia.
机译:来自视网膜母细胞瘤基因座远端的染色体带13q14.3的基因组材料在各种人类肿瘤中反复丢失,表明迄今尚未发现的肿瘤抑制机制。到现在为止,在最小限度缺失的区域还没有发现致病突变。但是,在丢失一个关键区域拷贝的B细胞慢性淋巴细胞性白血病肿瘤中,各个候选肿瘤抑制基因的下调因子> 2,这是正常基因剂量效应所预期的。这一发现表明表观遗传的致病机理。我们发现关键区域的两个副本异步复制,表明两个副本13q14.3的差异染色质包装。尽管我们还检测到位于关键区域的基因的单等位基因沉默,但单等位基因表达源自母本或父本拷贝,但不包括印迹机制。 DNA甲基化分析显示该区域要甲基化的一个CpG岛。此CpG岛的DNA脱甲基和整体组蛋白超乙酰化诱导双等位基因表达,而复制时机不受影响。我们提出,差异复制时机代表了一个早期的表观遗传标记,可以区别13q14.3的两个拷贝,从而导致差异染色质包装和单等位基因表达。因此,删除13q14.3的单个有效拷贝会导致候选基因的显着下调和功能丧失,从而为B细胞慢性淋巴细胞性白血病中13q14.3的遗传损伤和表观遗传沉默的相互作用提供了一个模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号